Blue Ridge Real Estate Company
BRRE
$9.50
$0.101.06%
| Weiss Ratings | BRRE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D | |||
| Rating Factors | BRRE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BRRE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.17 | |||
| Price History | BRRE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.74% | |||
| 30-Day Total Return | 11.76% | |||
| 60-Day Total Return | 11.76% | |||
| 90-Day Total Return | 11.76% | |||
| Year to Date Total Return | 11.76% | |||
| 1-Year Total Return | 5.56% | |||
| 2-Year Total Return | -20.83% | |||
| 3-Year Total Return | -13.64% | |||
| 5-Year Total Return | 63.79% | |||
| 52-Week High % Change | -3.06% | |||
| 52-Week Low % Change | 26.67% | |||
| Price | BRRE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $9.80 | |||
| 52-Week Low Price | $7.50 | |||
| 52-Week Low Price (Date) | Nov 25, 2024 | |||
| 52-Week High Price (Date) | Feb 20, 2025 | |||
| Valuation | BRRE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 22.88M | |||
| Enterprise Value | 10.95M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.26 | |||
| Earnings Per Share Growth | -125.91% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.36 | |||
| Price/Book (Q) | 1.06 | |||
| Enterprise Value/Revenue (TTM) | 1.60 | |||
| Price | $9.50 | |||
| Enterprise Value/EBITDA (TTM) | -8.57 | |||
| Enterprise Value/EBIT | -6.27 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BRRE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 2.41M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BRRE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 570 443 8433 | |||
| Address | 5 Blue Ridge Court Blakeslee, PA 18610 | |||
| Website | www.brreco.com | |||
| Country | United States | |||
| Year Founded | 1820 | |||
| Profitability | BRRE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -25.57% | |||
| Profit Margin | -9.13% | |||
| Management Effectiveness | BRRE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -4.63% | |||
| Return on Equity | -- | |||
| Income Statement | BRRE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 6.82M | |||
| Total Revenue (TTM) | 6.82M | |||
| Revenue Per Share | $2.83 | |||
| Gross Profit (TTM) | 100.70K | |||
| EBITDA (TTM) | -1.28M | |||
| EBIT (TTM) | -1.74M | |||
| Net Income (TTM) | -622.70K | |||
| Net Income Avl. to Common (TTM) | -622.70K | |||
| Total Revenue Growth (Q YOY) | 9.58% | |||
| Earnings Growth (Q YOY) | 84.87% | |||
| EPS Diluted (TTM) | -0.26 | |||
| EPS Diluted Growth (Q YOY) | 84.88% | |||
| Balance Sheet | BRRE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 11.98M | |||
| Cash Per Share (Q) | $4.97 | |||
| Total Current Assets (Q) | 12.81M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 21.60M | |||
| Current Ratio (Q) | 12.394 | |||
| Book Value Per Share (Q) | $8.97 | |||
| Total Assets (Q) | 23.40M | |||
| Total Current Liabilities (Q) | 1.03M | |||
| Total Debt (Q) | 41.00K | |||
| Total Liabilities (Q) | 1.80M | |||
| Total Common Equity (Q) | 21.60M | |||
| Cash Flow | BRRE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 346.60K | |||
| Cash from Financing (TTM) | 29.50K | |||
| Net Change in Cash (TTM) | 306.20K | |||
| Levered Free Cash Flow (TTM) | -1.47M | |||
| Cash from Operations (TTM) | -69.90K | |||
